Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study

BACKGROUND/OBJECTIVES: Data on the comparative effectiveness of oral antidiabetics on cardiovascular outcomes in a clinical practice setting are limited. This study sought to determine whether a differential risk of cardiovascular disease (CVD) exists for the combination of a dipeptidyl peptidase-4...

Descripción completa

Detalles Bibliográficos
Autores principales: Seong, Jong-Mi, Choi, Nam-Kyong, Shin, Ju-Young, Chang, Yoosoo, Kim, Ye-Jee, Lee, Joongyub, Kim, Ju-Young, Park, Byung-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439115/
https://www.ncbi.nlm.nih.gov/pubmed/25992614
http://dx.doi.org/10.1371/journal.pone.0124287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439115/
https://www.ncbi.nlm.nih.gov/pubmed/25992614
http://dx.doi.org/10.1371/journal.pone.0124287

Ejemplares similares